26 results
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
23 Aug 23
Tiziana Life Sciences Announces Appointment of William A. Clementi as Chief Development Officer
10:30am
and device-drug products. Clementi Ltd also provides high-level cGMP and GCP oversight.
Dr. Clementi is a graduate of Boston University and the University
20-F/A
2022 FY
TLSA
Tiziana Life Sciences Ltd
13 Jun 23
Annual report (foreign) (amended)
12:37pm
Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S … Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal
20-F
2018 FY
TLSA
Tiziana Life Sciences Ltd
4 Apr 19
Annual report (foreign)
6:07am
been prepared in accordance with IFRS, as issued by the IASB, and audited in accordance with the standards of the Public Company Accounting Oversight … , principal investigators and clinical trial sites. If we fail to exercise adequate oversight over any of our CROs or if we or any of our CROs fail to comply
F-1/A
86mtto
17 Oct 18
Registration statement (foreign) (amended)
8:40pm
F-1
fzasu2e bjk28uz5
26 Jul 18
Registration statement (foreign)
5:06pm
DRS
af921x0
17 Jul 19
Draft registration statement
12:00am
F-1
hpd7b6kpn1o1q8
5 Aug 19
Registration statement (foreign)
4:28pm
F-1/A
2fyfnszg 6977
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
kngqj0r7ts5zvj38wm0e
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
DRS/A
ysc0js2wrw5859r e9
10 May 18
Draft registration statement (amended)
12:00am
F-1/A
tr65yfzm7ojdjhduj
30 Oct 18
Registration statement (foreign) (amended)
12:00am
POS AM
tav4x
14 Nov 18
Prospectus update (post-effective amendment)
12:00am
6-K
EX-1.1
8kaz 2442hm2vefep9
1 Sep 23
Report of Foreign Private Issuer
4:46pm
F-1/A
hoppskw2e0rvve 60snr
23 Oct 18
Registration statement (foreign) (amended)
1:04pm
424B4
oxj5vc32x
21 Nov 18
Prospectus supplement with pricing info
6:10am